Artiva Biotherapeutics, Inc. SEC filings ARTV
Artiva Biotherapeutics, Inc. has 232 filings in SEC EDGAR's recent list, going back to Jul 10, 2020. Its latest annual report, Form ARS, was filed on Aug 3, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 27, 2026 (results of operations, exit or restructuring costs). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Nov 3, 2026 | Nov 2, 2026 |
| 4 | Insider transaction | Nov 3, 2026 | Nov 2, 2026 |
| 4 | Insider transaction | Nov 3, 2026 | Nov 2, 2026 |
| 4 | Insider transaction | Nov 3, 2026 | Nov 2, 2026 |
| 4 | Insider transaction | Oct 7, 2026 | Oct 6, 2026 |
| 144 | Notice of proposed sale | Oct 6, 2026 | — |
| 4 | Insider transaction | Oct 6, 2026 | Oct 5, 2026 |
| 4 | Insider transaction | Oct 6, 2026 | Oct 5, 2026 |
| 4 | Insider transaction | Oct 6, 2026 | Oct 5, 2026 |
| 4 | Insider transaction | Oct 6, 2026 | Oct 5, 2026 |
| 4 | Insider transaction | Sep 15, 2026 | Sep 15, 2026 |
| 4 | Insider transaction | Sep 14, 2026 | Sep 10, 2026 |
| 4 | Insider transaction | Sep 14, 2026 | Sep 10, 2026 |
| 4 | Insider transaction | Sep 14, 2026 | Sep 10, 2026 |
| 4 | Insider transaction | Sep 14, 2026 | Sep 10, 2026 |
| 4 | Insider transaction | Sep 14, 2026 | Sep 10, 2026 |
| 4 | Insider transaction | Sep 14, 2026 | Sep 10, 2026 |
| 4 | Insider transaction | Sep 14, 2026 | Sep 10, 2026 |
| 4 | Insider transaction | Sep 14, 2026 | Sep 10, 2026 |
| 4 | Insider transaction | Sep 11, 2026 | Sep 9, 2026 |
| 4 | Insider transaction | Sep 11, 2026 | Sep 9, 2026 |
| 4 | Insider transaction | Sep 11, 2026 | Sep 9, 2026 |
| 4 | Insider transaction | Sep 11, 2026 | Sep 9, 2026 |
| 4 | Insider transaction | Sep 9, 2026 | Sep 8, 2026 |
| 4 | Insider transaction | Sep 8, 2026 | Sep 8, 2026 |
| 4 | Insider transaction | Sep 8, 2026 | Sep 8, 2026 |
| 4 | Insider transaction | Sep 8, 2026 | Sep 8, 2026 |
| 4 | Insider transaction | Sep 8, 2026 | Sep 8, 2026 |
| 4 | Insider transaction | Sep 8, 2026 | Sep 8, 2026 |
| 4 | Insider transaction | Sep 8, 2026 | Sep 8, 2026 |
| 4 | Insider transaction | Sep 8, 2026 | Sep 8, 2026 |
| 144 | Notice of proposed sale | Sep 8, 2026 | — |
| 4 | Insider transaction | Sep 4, 2026 | Sep 3, 2026 |
| 4 | Insider transaction | Sep 4, 2026 | Sep 3, 2026 |
| 4 | Insider transaction | Sep 4, 2026 | Sep 3, 2026 |
| 4 | Insider transaction | Sep 4, 2026 | Sep 3, 2026 |
| 4 | Insider transaction | Aug 31, 2026 | Aug 27, 2026 |
| 144 | Notice of proposed sale | Aug 27, 2026 | — |
| 4 | Insider transaction | Aug 19, 2026 | Aug 18, 2026 |
| 144 | Notice of proposed sale | Aug 18, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 10, 2026 | — |
| 4 | Insider transaction | Jul 31, 2026 | Jul 29, 2026 |
| 4 | Insider transaction | Jul 28, 2026 | Jul 24, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jul 23, 2026 | — |
| 4 | Insider transaction | Jul 23, 2026 | Jul 21, 2026 |
| 4/A | Filing | Jul 23, 2026 | Jul 13, 2026 |
| 4 | Insider transaction | Jul 20, 2026 | Jul 16, 2026 |
| 4 | Insider transaction | Jul 14, 2026 | Jul 10, 2026 |
| 4 | Insider transaction | Jun 29, 2026 | Jun 25, 2026 |
| 4 | Insider transaction | Jun 16, 2026 | Jun 12, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jun 15, 2026 | — |
| 4 | Insider transaction | Jun 11, 2026 | Jun 9, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | May 28, 2026 | — |
| 4 | Insider transaction | May 28, 2026 | May 11, 2026 |
| 4 | Insider transaction | May 19, 2026 | May 19, 2026 |
| 4 | Insider transaction | May 19, 2026 | May 19, 2026 |
| 4 | Insider transaction | May 19, 2026 | May 19, 2026 |
| 4 | Insider transaction | May 19, 2026 | May 19, 2026 |
| 4 | Insider transaction | May 19, 2026 | May 19, 2026 |
| 4 | Insider transaction | May 19, 2026 | May 18, 2026 |
| 144 | Notice of proposed sale | May 18, 2026 | — |
| 144 | Notice of proposed sale | May 18, 2026 | — |
| 144 | Notice of proposed sale | May 18, 2026 | — |
| 144 | Notice of proposed sale | May 18, 2026 | — |
| 144 | Notice of proposed sale | May 18, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 18, 2026 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | May 13, 2026 | — |
| 4 | Insider transaction | May 13, 2026 | May 11, 2026 |
| 4 | Insider transaction | Mar 10, 2026 | Mar 10, 2026 |
| 3 | Initial insider ownership | Feb 24, 2026 | Feb 18, 2026 |
| 4 | Insider transaction | Feb 19, 2026 | Feb 18, 2026 |
| 3 | Initial insider ownership | Feb 19, 2026 | Feb 18, 2026 |
| 4 | Insider transaction | Feb 18, 2026 | Feb 15, 2026 |
| 4 | Insider transaction | Feb 18, 2026 | Feb 15, 2026 |
| 4 | Insider transaction | Feb 18, 2026 | Feb 15, 2026 |
| 4 | Insider transaction | Feb 18, 2026 | Feb 15, 2026 |
| 4 | Insider transaction | Feb 18, 2026 | Feb 15, 2026 |
| 4 | Insider transaction | Dec 15, 2025 | Dec 15, 2025 |
| 144 | Notice of proposed sale | Dec 15, 2025 | — |
| 4 | Insider transaction | Dec 12, 2025 | Dec 12, 2025 |
| 4 | Insider transaction | Dec 12, 2025 | Dec 12, 2025 |
| 4 | Insider transaction | Dec 12, 2025 | Dec 12, 2025 |
| 4 | Insider transaction | Dec 12, 2025 | Dec 12, 2025 |
| 4 | Insider transaction | Nov 17, 2025 | Nov 15, 2025 |
| 4 | Insider transaction | Nov 17, 2025 | Nov 15, 2025 |
| 4 | Insider transaction | Nov 17, 2025 | Nov 15, 2025 |
| 4 | Insider transaction | Nov 17, 2025 | Nov 15, 2025 |
| 4 | Insider transaction | Nov 17, 2025 | Nov 15, 2025 |
| 144 | Notice of proposed sale | Nov 17, 2025 | — |
| 4 | Insider transaction | Oct 17, 2025 | Oct 17, 2025 |
| 144 | Notice of proposed sale | Oct 17, 2025 | — |
| 4 | Insider transaction | Aug 18, 2025 | May 15, 2025 |
| 4 | Insider transaction | Aug 18, 2025 | May 15, 2025 |
| 4 | Insider transaction | Aug 18, 2025 | May 15, 2025 |
| 4 | Insider transaction | Aug 18, 2025 | May 15, 2025 |
| 4 | Insider transaction | Aug 18, 2025 | May 15, 2025 |
| 144 | Notice of proposed sale | Aug 15, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 16, 2025 | — |
| 4 | Insider transaction | Jun 26, 2025 | Jun 24, 2025 |
| 4 | Insider transaction | Jun 26, 2025 | Jun 24, 2025 |
| 4 | Insider transaction | Jun 26, 2025 | Jun 24, 2025 |
| 4 | Insider transaction | Jun 26, 2025 | Jun 24, 2025 |
| 4 | Insider transaction | Jun 26, 2025 | Jun 24, 2025 |
| 4 | Insider transaction | Jun 26, 2025 | Jun 24, 2025 |
| 4 | Insider transaction | Jun 26, 2025 | Jun 24, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2025 | — |
| 4 | Insider transaction | Apr 25, 2025 | Apr 8, 2025 |
| 3 | Initial insider ownership | Apr 25, 2025 | Apr 8, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Apr 23, 2025 | — |
| 4 | Insider transaction | Mar 7, 2025 | Mar 5, 2025 |
| 4 | Insider transaction | Feb 28, 2025 | Feb 26, 2025 |
| 4 | Insider transaction | Feb 28, 2025 | Feb 26, 2025 |
| 4 | Insider transaction | Feb 28, 2025 | Feb 26, 2025 |
| 4 | Insider transaction | Feb 28, 2025 | Feb 26, 2025 |
| 4 | Insider transaction | Feb 28, 2025 | Feb 26, 2025 |
| 4 | Insider transaction | Jan 29, 2025 | Jan 28, 2025 |
| 3 | Initial insider ownership | Jan 29, 2025 | Jan 28, 2025 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| 4 | Insider transaction | Oct 22, 2024 | Oct 21, 2024 |
| 3 | Initial insider ownership | Oct 22, 2024 | Oct 21, 2024 |
| 4 | Insider transaction | Sep 13, 2024 | Sep 12, 2024 |
| 4 | Insider transaction | Sep 13, 2024 | Sep 12, 2024 |
| 4 | Insider transaction | Sep 13, 2024 | Sep 12, 2024 |
| 4 | Insider transaction | Sep 13, 2024 | Sep 12, 2024 |
| 4 | Insider transaction | Sep 13, 2024 | Sep 12, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Sep 3, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Aug 1, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Aug 1, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Aug 1, 2024 | — |
| SC 13D | Ownership over 5% (active) | Jul 29, 2024 | — |
| SC 13D | Ownership over 5% (active) | Jul 29, 2024 | — |
| 4 | Insider transaction | Jul 24, 2024 | Jul 22, 2024 |
| 4 | Insider transaction | Jul 24, 2024 | Jul 22, 2024 |
| 4 | Insider transaction | Jul 22, 2024 | Jul 22, 2024 |
| 4 | Insider transaction | Jul 22, 2024 | Jul 22, 2024 |
| 4 | Insider transaction | Jul 22, 2024 | Jul 22, 2024 |
| 4 | Insider transaction | Jul 22, 2024 | Jul 22, 2024 |
| 4 | Insider transaction | Jul 22, 2024 | Jul 18, 2024 |
| 3 | Initial insider ownership | Jul 18, 2024 | Jul 18, 2024 |
| 3 | Initial insider ownership | Jul 18, 2024 | Jul 18, 2024 |
| 3 | Initial insider ownership | Jul 18, 2024 | Jul 18, 2024 |
| 3 | Initial insider ownership | Jul 18, 2024 | Jul 18, 2024 |
| 3 | Initial insider ownership | Jul 18, 2024 | Jul 18, 2024 |
| 3 | Initial insider ownership | Jul 18, 2024 | Jul 18, 2024 |
| 3 | Initial insider ownership | Jul 18, 2024 | Jul 18, 2024 |
| 3 | Initial insider ownership | Jul 18, 2024 | Jul 18, 2024 |
| 3 | Initial insider ownership | Jul 18, 2024 | Jul 18, 2024 |
| 3 | Initial insider ownership | Jul 18, 2024 | Jul 18, 2024 |
| 3 | Initial insider ownership | Jul 18, 2024 | Jul 18, 2024 |
| 3 | Initial insider ownership | Jul 18, 2024 | Jul 18, 2024 |
| 3 | Initial insider ownership | Jul 18, 2024 | Jul 18, 2024 |
| 3 | Initial insider ownership | Jul 18, 2024 | Jul 18, 2024 |
| 3 | Initial insider ownership | Jul 18, 2024 | Jul 18, 2024 |
| 3 | Initial insider ownership | Jul 18, 2024 | Jul 18, 2024 |
| 3 | Initial insider ownership | Jul 18, 2024 | Jul 18, 2024 |
Showing 156 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- ARTV (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1817241
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.